VBI Vaccines Picks 2 Coronavirus Vaccine Candidates for Further Development
VBI Vaccines (NASDAQ: VBIV) was a stock market star on Thursday, following some positive news items about its development of a coronavirus vacicine...or vaccines.
The company said it has chosen two vaccine candidates for further development. Both VBI-2901 and VBI-2902 have the potential to be one-dose vaccines, which is attention-grabbing as some of the more advanced candidates being developed by rivals require two doses.
Image source: Getty Images.
Source Fool.com
